Deutsche Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Deutsche Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-675	Closed	-$5K	–	6085
2014 Q1	$5K	Buy	+675	New	+$34.6K	﹤0.01%	5194

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Deutsche Bank's XBI Position: Q3 2024 in Review

Deutsche Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2024, closing a stake of 113 shares — an estimated $10.5K sold.

Deutsche Bank first reported a position in XBI in Q2 2013 and held it in 29 quarters. The position peaked at $453M in Q1 2018. 769 funds tracked by Wall St. Rank hold XBI as of Q3 2024.

Deutsche Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2024 after selling out during the quarter.
Deutsche Bank sold 113 State Street SPDR S&P Biotech ETF shares in Q3 2024, an estimated $10.5K.
Deutsche Bank first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 29 quarters.
Deutsche Bank's State Street SPDR S&P Biotech ETF position peaked at $453M in Q1 2018.
769 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2024.

Based on Deutsche Bank's 13F filing for Q3 2024, filed 13 Nov 2024.